Short, medium and long-term effect of Coronavirus disease 2019 on the cardiovascular system.

Patients with COVID-19 disease have a very high risk of short-term and long-term adverse cardiovascular events, including death from cardiovascular causes. We propose an epidemiological surveillance study to determine the rate of adverse cardiovascular events (cardiovascular death, myocardial infarction, cardiovascular accident, cardiac arrhythmias = at the time of infection, 30 days, 6 and 12 months, in patients confirmed by COVID- 19. In addition, to determine the relationship between the use of angiotesin-2-converting enzyme inhibitors, angiotesin-2 receptor blockers, and non-steroidal anti-inflammatory drugs in the presentation of severe or fatal symptoms due to COVID-19. Through a case-control study We will develop early warning tools, prediction and risk stratification of adverse cardiovascular events in patients with COVID-19. Through a web page, the information generated will be immediately disseminated and the tools developed will be openly used.